L

Leerink Partners LLC, Research Division

500 employees

Describes equity research, investment banking, and asset management services.

Investor insights

Sectors invested in

Health Care12
Biotechnology12
Medical6
Therapeutics5
Genetics5
Biopharma4
Life Science3
Pharmaceutical3
Cell Therapy2
Private cloud-based analytics solutions2
Clinical intelligence2
Solutions for value-based healthcare2
Analytics2
Transforms disparate data into actionable insights2
Clinical analytics2
SaaS2
Clinical Trials2
Precision Medicine1
Rare Disease1
ceDNA Genetic Medicine1

Funding rounds participated in

$65M sweet spot round size

Most of their 16 investments are in rounds between $30M and $100M

Investor type

Investment Bank

Basic info

Industry

investment banking

Sectors

Health Care
Banking

Date founded

1995

Investments made

K

Kinnate Biopharma, Inc. raised $98M on August 26, 2020

Investors: Nextech Invest, Surveyor Capital, Viking Global Investors, OrbiMed Advisors, Vida Ventures, LLC, Logos Global Management, LP, RA Capital Management, L.P. and Leerink Partners LLC, Research Division

A

AlloVir raised $120M on May 23, 2019

Investors: Gilead Sciences, Redmile Group, Samsara BioCapital, The Invus Group and Leerink Partners LLC, Research Division

F

Fulcrum Therapeutics raised $80M on September 5, 2018

Investors: NS Investment, 6 Dimensions Capital, Casdin Capital, LLC, Section 32, Foresite Capital and Leerink Partners LLC, Research Division

P

Precision BioSciences, Inc. raised $110M on June 8, 2018

Investors: Vivo Capital, Gilead Sciences, Ridgeback Capital Management LLC, Osage University Partners (OUP), RA Capital Management, L.P., The Longevity Fund, venBio Partners, OCV and Leerink Partners LLC, Research Division

F

FogPharma raised $66M on May 16, 2018

Investors: Horizons Ventures, GV, 6 Dimensions Capital, WuXi AppTec, Blue Pool Capital, Nan Fung Group and Leerink Partners LLC, Research Division

G

Generation Bio raised $100M on February 27, 2018

Investors: Foresite Capital, The Invus Group, Casdin Capital, LLC and Leerink Partners LLC, Research Division

A

AVROBIO raised $60M on February 1, 2018

Investors: Aisling Capital, Atlas Venture, SV Life Sciences, Clarus Ventures, LLC, Brace Pharma Capital, Morningside Venture Partners and Leerink Partners LLC, Research Division

A

Arcus Biosciences raised $107M on November 13, 2017

Investors: The Column Group, GV, The Invus Group, Hillhouse Capital Management, Wellington Management, Foresite Capital and Leerink Partners LLC, Research Division

R

REPLIMUNE LIMITED raised $55M on September 8, 2017

Investors: Omega Funds, Atlas Venture, Redmile Group, Foresite Capital, Forbion and Leerink Partners LLC, Research Division

U

Undisclosed raised $50M on March 30, 2017

Investors: Foresite Capital, RTW Investments, LP, RA Capital Management, L.P., Perceptive Advisors, Biogen Idec and Leerink Partners LLC, Research Division

FAQ